A federal judge tossed a lawsuit filed in 2010 accusing Medtronic (NYSE:MDT) of violating patents held by W.L. Gore & Associates covering stent graft manufacturing techniques.
Legal News
MassDevice.com +3 | The top 3 med-tech stories for June 19, 2012
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Supreme Court denies ex-McKesson CEO’s appeal
The Supreme Court refused to review the conviction of former McKesson (NYSE:MCK) chairman & CEO Charles McCall in an accounting scandal, meaning his 10-year prison sentence will stand.
The high court provided no comment on the denial. San Francisco, Calif.-based McKesson is the largest drug distributor in the U.S., and also deals in healthcare information technology products.
Leaked Fresenius memo spurs FDA probe | Legal News
FDA investigators want answers from Fresenius (NYSE:FMS) after a dialysis website leaked a copy of an internal memo released to the company’s in-house dialysis centers.
The memo detailed adverse events possibly associated with improper use of its Granuflo dialysis concentrate, including a possible 5-fold increase in heart-attack risk associated with the compound.
U.K. settles cancer risk for substandard breast implants | MassDevice.com On Call
MASSDEVICE ON CALL — A U.K. researcher tasked with defining the health risk for the nearly 50,000 women who were given substandard implants concluded that the devices were unlikely to cause long-term health problems.
The implants were pulled from shelves amid quite a kerfuffle last year when investigators discovered that Poly Implant Prosthèse was using industrial grade silicon, rather than medical grade.
Shareholders accuse St. Jude Medical of hiding Riata problems
St. Jude Medical (NYSE:STJ) shareholders filed a lawsuit this week accusing the company and its CEO of down-playing device failures that led to the recall of a set of defibrillator leads in a "scheme" to artificially inflate the company’s share price.
Federal Circuit reverses part of Bard’s $371M patent win over Gore
How to reduce breast cancer risk? Avoid excess imaging, researchers say | MassDevice.com On Call
MASSDEVICE ON CALL — University of California researchers recommended that women be more wary of breast cancer imaging exams, warning that excess testing may increase a women’s risk of developing breast cancer.
Reserachers dug deeper into an Institute of Medicine report on the environmental factors contributing to breast cancer, focusing on radiation exposure tied to breast cancer diagnostic imaging exams.
Intuitive battles consolidation of da Vinci injury lawsuits | Legal News
Healthcare reform beyond the Supreme Court decision | Wall Street Beat
The highly anticipated U.S. Supreme Court decision on the legality of President Barack Obama’s Affordable Care Act will ripple through different areas of U.S. Healthcare, with different outcomes tied to each possibility.
The Supremes will this month unveil their decision on theconstitutionality of the healthcare reform law’s individual insurance mandate, which would require nearly all U.S. citizens to carry health insurance. Should they strike down the measure, they will further decide whether the rest of the health law can survive on its own.
Judges skeptical of $60M NeuroVision win over NuVasive | MassDevice.com Legal News
A trio of federal judges this week expressed skepticism over a $60 million trademark infringement win NeuroVision Medical Products logged against NuVasive Inc. (NSDQ:NUVA) in 2010.
NuVasive appealed the decision, arguing in March that the judge who handled the case "fundamentally misunderstood trademark law" and "exhibited hostility toward NuVasive’s counsel in front of the jury."